Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$105.21 - $117.21 $331,832 - $369,680
-3,154 Closed
0 $0
Q1 2021

May 17, 2021

SELL
$102.3 - $112.62 $1.46 Million - $1.61 Million
-14,303 Reduced 81.93%
3,154 $341,000
Q4 2020

Feb 16, 2021

BUY
$80.49 - $108.67 $291,937 - $394,146
3,627 Added 26.23%
17,457 $1.85 Million
Q2 2020

Aug 14, 2020

BUY
$73.37 - $98.18 $42,481 - $56,846
579 Added 4.37%
13,830 $1.36 Million
Q1 2020

May 15, 2020

SELL
$64.5 - $97.79 $153,252 - $232,349
-2,376 Reduced 15.2%
13,251 $1.01 Million
Q2 2019

Aug 14, 2019

BUY
$65.7 - $83.98 $23,192 - $29,644
353 Added 2.31%
15,627 $1.14 Million
Q2 2018

Aug 14, 2018

SELL
$89.78 - $106.23 $58,267 - $68,943
-649 Reduced 4.08%
15,274 $1.42 Million
Q1 2018

May 15, 2018

SELL
$92.01 - $123.21 $141,143 - $189,004
-1,534 Reduced 8.79%
15,923 $1.51 Million
Q4 2017

Feb 13, 2018

SELL
$89.56 - $98.21 $95,023 - $104,200
-1,061 Reduced 5.73%
17,457 $1.69 Million
Q3 2017

Nov 14, 2017

BUY
$69.85 - $89.22 $1.29 Million - $1.65 Million
18,518
18,518 $1.65 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $318B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Lombard Odier Asset Management (Europe) LTD Portfolio

Follow Lombard Odier Asset Management (Europe) LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Europe) LTD, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Europe) LTD with notifications on news.